Labeling lindane.Each year in the United States, up to 1 million prescriptions are written for lindane lindane: see insecticides. lotion and shampoo to treat lice and scabies scabies (skā`bēz), highly contagious parasitic skin disease caused by the itch mite (Sarcoptes scabiei). The disease is also known as itch. , mostly in school-age children. To help consumers avoid adverse reactions associated with lindane, which include neurologic symptoms ranging from dizziness to seizures, on 28 March 2003 the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. issued a public health advisory and announced significant changes in the required labeling of these products. Labels must emphasize that lindane products should be used with caution in patients weighing less than 110 lbs and are not recommended for infants. Pharmacists must dispense a leaflet with every prescription, and containers are limited to 1- or 2-ounce sizes to avoid misuse or overuse overuse Health care The common use of a particular intervention even when the benefits of the intervention don't justify the potential harm or cost–eg, prescribing antibiotics for a probable viral URI. Cf Misuse, Underuse. . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion